Share-Based Compensation (Stock Appreciation Rights Activity) (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Oct. 28, 2023 USD ($) $ / shares shares
Stock Appreciation Rights Activity, Number of Underlying Shares
Number of Underlying Shares, Beginning Balance at January 30, 2021 | shares	190,589
Number of Underlying Shares, Exercised | shares	(132,689)
Number of Underlying Shares, Forfeited | shares	(23,700)
Number of Underlying Shares, Ending Balance at July 31, 2021 | shares	34,200
Number of Underlying shares, Stock appreciation rights exercisable | shares	34,200
Stock Appreciation Rights, Weighted-Average Exercise Price
Weighted-Average Grant Date Fair Value, Beginning Balance | $ / shares	$ 29.43
Weighted-Average Exercise Price, Exercised | $ / shares	25.95
Weighted-Average Exercise Price, Forfeited or expired | $ / shares	45.69
Weighted-Average Grant Date Fair Value, Ending Balance | $ / shares	31.65
Weighted-Average Exercise Price, Stock appreciation rights exercisable | $ / shares	$ 31.65
Aggregate Intrinsic Value, Outstanding | $	$ 926
Aggregate Intrinsic Value, Stock appreciation rights exercisable | $	$ 926
Weighted-Average Remaining Contractual Life, Outstanding	9 months 18 days
Weighted-Average Remaining Contractual Life, Stock appreciation rights exercisable	9 months 18 days
Stock Appreciation Rights
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $	$ 1,292